ArticleScientific reports2025
The PI3K-AKT-mTOR signaling pathway mediates epithelial mesenchymal transition and cytoskeletal architecture changes induce to renal fibrosis after Bisphenol S exposure.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- 4H-CRCXL Mitigates RasV12-Induced Phenotypes in Glioblastoma Model of Drosophila.Molecular carcinogenesis · 2026Article
- Unveiling the role of the PI3K/Akt signaling pathway in follicular development and non-malignant ovarian dysfunction: a comprehensive review.Journal of ovarian research · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Bisphenol S (BPS) is considered a good substitute for bisphenol A (BPA) in industrial applications, and data suggest that the kidney is an important injury site after BPS exposure. However, the phenotype of kidney injury induced by BPS exposure and the mechanism of its damage remain unknown. Therefore, this study aims to investigate the phenotype and specific mechanism of kidney injury induced by BPS exposure. SD rats are treated with three different doses of BPS (50 mg/kg body weight(b.w.), 100 mg/kg b.w., and 150 mg/ kg b.w.), and HK-2 cells are treated with 100 µM BPS, 200 µM and 400 µM BPS to mimic the in vitro and in vivo environment of BPS exposure-induced kidney injury. Meanwhile, the potential mechanism of BPS exposure-induced kidney injury was screened by RNA sequencing and further verified by in vitro experiments. BPS exposure induces cytoskeletal architecture damage and EMT transformation in HK-2 cells, promoting renal fibrosis. In addition, it was found that activation of the PI3K-AKT-mTOR signaling pathway plays a key role in cytoskeletal architecture damage and EMT transformation in HK-2, and after inhibition of PI3K-AKT-mTOR signaling by Wortmannin, the cytoskeletal architecture disorders, and EMT are partially reversed. In conclusion, we found that the activation of the PI3K-AKT-mTOR signaling pathway can mediate disturbed cytoskeletal architecture and EMT to induce renal fibrosis after BPS exposure.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.